3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
3
Leiomyoma
2
cyclopia sequence
1
Vomiting
1
Urinary Bladder Neoplasms
1
Prostatic Neoplasms
1
Polycystic Ovary Syndrome
1
Pancreatic Neoplasms
1
Pain
1
Non-Muscle Invasive Bladder Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Nausea
1
Myasthenia Gravis
1
Melanoma
1
Lymphoma, T-Cell
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma
1
Lung Neoplasms
1
Lower Urinary Tract Symptoms
1
Insulin Resistance
1
Infertility
1
Hyperandrogenism
1
Hot Flashes
1
Head and Neck Neoplasms
1
Endometrial Neoplasms
1
Diarrhea
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Dexamethasone
6
fosaprepitant
4
Calcium Dobesilate
4
Aprepitant
4
dexamethasone acetate
2
dexamethasone 21-phosphate
2
auricularum
2
Palonosetron
2
Ondansetron
2
Granisetron
2
Cisplatin
2
dolasetron
1
casopitant
1
Surveys and Questionnaires
1
Sugars
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Radiotherapy
1
Platinum
1
Neoadjuvant Therapy
1
Methadone
1
Lorazepam
1
Interviews as Topic
1
Immunoenzyme Techniques
1
Esomeprazole
1
Diphenhydramine
1
Cyproheptadine
1
Cyclophosphamide
1
Chemotherapy, Adjuvant
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Vomiting
×
Sugars
×
Clear all
NCT00206440
2018-12-06
NEXIUM
Baylor Breast Care Center
Phase 3
Terminated
43 enrolled
5 charts